Trial
NCT03955146
Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Kyntra Bio
Collaborators
—
Condition
Idiopathic Pulmonary Fibrosis
Intervention
Pamrevlumab
Why stopped
Study did not meet its primary endpoint.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-09-19